信邦制药：公司从道地药材基地采购的中药材用于自身生产中药饮片和中成药

Group 1 - The core viewpoint of the article is that the company has established a strategic reserve mechanism for commonly used Chinese medicinal materials to mitigate market volatility risks [1] - The company sources its Chinese medicinal materials from authentic medicinal material bases for its own production of Chinese medicinal slices and proprietary Chinese medicines [1] - The strategic reserve mechanism is designed to effectively reduce the impact of price fluctuations in Chinese medicinal materials on the company's operations [1]